On call. September 11 was an emotional day for all of us, but September 12 was a confusing day for me. I read two newspapers that reported on research in the New England Journal of Medicine. The New York Times headline said: "Prostate cancer surgery found to cut death risk," but the Washington Post announced: "Studies find no advantage to prostate cancer surgery." Which was right?
作者信息
Simon Harvey B
出版信息
Harv Mens Health Watch. 2002 Dec;7(5):8.
PMID:12499134
Abstract
摘要
相似文献
2
Re: Prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial.关于：局限性前列腺癌中前列腺切除术与观察等待：斯堪的纳维亚前列腺癌研究组-4随机试验
J Natl Cancer Inst. 2009 Jan 21;101(2):124. doi: 10.1093/jnci/djn443. Epub 2009 Jan 13.
3
SPCG-4: a needed START to PIVOTal data to promote and protect evidence-based prostate cancer care.斯堪的纳维亚前列腺癌研究组4：推动和保护基于证据的前列腺癌护理的关键数据的必要开端。
J Natl Cancer Inst. 2008 Aug 20;100(16):1123-5. doi: 10.1093/jnci/djn259. Epub 2008 Aug 11.
4
The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.前列腺癌干预与观察试验：退伍军人事务部/美国国立癌症研究所/医疗保健研究与质量局合作研究项目#407（PIVOT）：一项随机对照试验的设计及基线结果，该试验比较了根治性前列腺切除术与对临床局限性前列腺癌男性进行观察等待的效果。
Contemp Clin Trials. 2009 Jan;30(1):81-7. doi: 10.1016/j.cct.2008.08.002. Epub 2008 Aug 23.
5
Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.关于以下内容的编辑评论：根治性前列腺切除术后或密切观察等待后的时间、症状负担、雄激素剥夺和自我评估的生活质量：斯堪的纳维亚前列腺癌随机研究组4号（SPCG-4）临床试验
Eur Urol. 2009 Feb;55(2):432. doi: 10.1016/j.eururo.2008.08.056. Epub 2008 Sep 2.
6
Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality.根治性前列腺切除术后前列腺特异性抗原复发时间与前列腺癌特异性死亡风险
J Urol. 2006 Oct;176(4 Pt 1):1404-8. doi: 10.1016/j.juro.2006.06.017.
7
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.亮丙瑞林治疗高危局限性前列腺癌的全球最新进展：美国视角——识别诊断时术后或放疗后有前列腺癌死亡高风险的男性。
BJU Int. 2007 Jan;99 Suppl 1:13-6; discussion 17-8. doi: 10.1111/j.1464-410X.2007.06594.x.
8
Editorial comment on: Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial.关于以下内容的编辑评论：根治性前列腺切除术后或密切观察等待后的时间、症状负担、雄激素剥夺及自我评估的生活质量：斯堪的纳维亚前列腺癌随机研究组4号（SPCG - 4）临床试验
Eur Urol. 2009 Feb;55(2):431. doi: 10.1016/j.eururo.2008.08.055. Epub 2008 Sep 2.
9
[Prostate cancer].
Gan To Kagaku Ryoho. 2007 Nov;34(11):1740-4.
10
Radical prostatectomy versus watchful waiting in early prostate cancer.早期前列腺癌根治性前列腺切除术与观察等待的比较
J Insur Med. 2002;34(2):131-2.
Zotero 插件